Search results with tag "Low molecular weight heparin"
Guidance on prescribing of Low Molecular Weight Heparin ...
www.derbyshiremedicinesmanagement.nhs.ukLow molecular weight heparin (LMWH) provides effective, rapid anticoagulation and is used in the acute management of venous thromboembolic disease (VTE), often in conjunction with warfarin until INR target is reached. Those who are not suitable for oral anticoagulation may require extended
Guidelines on Perioperative Management of Anticoagulant ...
www.cec.health.nsw.gov.auanticoagulant, typically low molecular weight heparin (LMWH), during the interruption of a longer-acting anticoagulant, typically warfarin(1). Bridging therapy does not refer to the administration of a venous thromboembolism (VTE) prophylactic dose of an anticoagulant during the post-operative period.
Guideline: Venous thromboembolism (VTE) in pregnancy …
www.health.qld.gov.aulow molecular weight heparin, PE: pulmonary embolism, SCD: sequential compression device, VTE: venous thromboembolism, Queensland Clinical Guideline: VTE prophylaxis in pregnancy and the puerperium Refer to online version, destroy printed copies after use Page 4 of 24 .
The Management of Diabetic Ketoacidosis in Adults
diabetes-resources-production.s3.eu-west-1.amazonaws.com•Thromboprophylaxis with low molecular weight heparin • Consider ECG monitoring if potassium abnormal or concerns about cardiac status BOX 5: 12 to 24 HOURS Expectation: By 24 hours the ketonaemia and acidosis should have …
BRIDGING ANTICOAGULATION PROTOCOL FOR …
seslhd.health.nsw.gov.auantiplatelet drug discontinuation and resumption, dose and timing of Low Molecular Weight Heparin (LMWH) bridging, and International Normalised Ratio (INR) measurement schedule. o This should include patient and caregiver education on injection technique when outpatient LMWH bridging is required.
Guidelines For Antithrombotic Therapy
www.outcomes-umassmed.org3 I. INITIATION OF ANTICOAGULANT THERAPY A. Fractionated, Low Molecular Weight Heparin (LMWH) (SC Administration) • Lovenox 1 mg/kg (maximum dose 150 mg) every 12h (unstable angina, non-ST elevation
Enoxaparin use in Mechanical Heart Valve patients
zunis.orgCriteria for Use of Enoxaparin in Mechanical Valve Patients 11. Berndt N, Khan I, Gallo R. A complication in anticoagulation using low molecular weight heparin in a
Heparin-induced thrombocytopenia Guideline
www.healthcare.uiowa.edu* Available randomized controlled trials comparing unfractionated heparin and low molecular weight heparin (LMWH) treatment for VTE do not support a lower risk for HIT with LMWH.4,5 It is unclear if the absolute risk of HIT is so low that a true difference is difficult to prove or if there truly is no difference.3
Low Molecular Weight Heparin (Enoxaparin) Protocol - …
hospitals.vchca.orgJun 28, 2018 · 100 mg total for the first two doses (bolus + first 1 mg/kg dose) Maintenance 1 mg/kg SQ q 12 hours Age ≥ 75 years old Initial NO bolus, give 0.75 mg/kg SQ q 12 hours. Maximum dose of 75 mg for the first two doses Maintenance 0.75 mg/kg SQ q 12 hours Obesity Initial Use weight based dosing with maximum dose of 100 mg for the first two doses [3,6]